Chautauqua Capital Management’s Novo Nordisk NVO Stock Holding History

Chautauqua Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$35.6M	Sell	1,226,348 -60,298	-5%	-$1.67M	11.25%	1
2015 Q3	$34.9M	Buy	1,286,646 +22,410	+2%	+$635K	11.48%	1
2015 Q2	$34.6M	Buy	1,264,236 +263,064	+26%	+$7.4M	8.39%	3
2015 Q1	$26.7M	Sell	1,001,172 -436,484	-30%	-$10.1M	6.78%	7
2014 Q4	$30.4M	Buy	1,437,656 +289,488	+25%	+$6.47M	9.16%	5
2014 Q3	$27.3M	Buy	1,148,168 +120,964	+12%	+$2.78M	8.94%	5
2014 Q2	$23.7M	Sell	1,027,204 -906,856	-47%	-$20M	8.15%	6
2014 Q1	$44.1M	Buy	1,934,060 +29,700	+2%	+$633K	8.68%	5
2013 Q4	$35.2M	Sell	1,904,360 -40,420	-2%	-$704K	7.77%	6
2013 Q3	$32.9M	Buy	1,944,780 +1,494,930	+332%	+$25.1M	7.74%	7
2013 Q2	$6.97M	Buy	+449,850	New	+$7.49M	5.4%	8

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Chautauqua Capital Management's NVO Position: Q4 2015 in Review

Chautauqua Capital Management reduced its Novo Nordisk (NVO) stake by 4.7% in Q4 2015, selling an estimated $1.67M and leaving 1,226,348 shares worth $35.6M. The position accounts for 11.25% of the portfolio, ranked #1.

Chautauqua Capital Management first reported a position in NVO in Q2 2013 and has held it in 11 quarters since. The position peaked at $44.1M in Q1 2014. 548 funds tracked by Wall St. Rank hold NVO as of Q4 2015.

Chautauqua Capital Management held 1,226,348 shares of Novo Nordisk worth $35.6M as of Q4 2015.
Chautauqua Capital Management sold 60,298 Novo Nordisk shares in Q4 2015, an estimated $1.67M.
Novo Nordisk made up 11.25% of Chautauqua Capital Management's portfolio in Q4 2015, its #1 holding.
Chautauqua Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 11 quarters since.
Chautauqua Capital Management's Novo Nordisk position peaked at $44.1M in Q1 2014.
548 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2015.

Based on Chautauqua Capital Management's 13F filing for Q4 2015, filed 22 Jan 2016.